Our Board of Directors bring their expertise and contributions in consumer health and technology to the Tivic Health team, as we scale up commercial operations and develop new bioelectronics therapies.
Jennifer is a consummate hi-tech business developer with a history of developing markets from new technologies such as Thin Film Electronics ($480M market cap in 5 yrs) with Xerox PARC. With over 20 years at Xerox PARC, she held multiple go-to-market roles and marketed multiple award-winning products. MBA, Santa Clara University. Jennifer has been featured in Authority Magazine and Thrive Global as a female leader who is shaking up things in the industry.
Sheryle is Professor of Entrepreneurship, Hult International Business School. She is an experienced public company CEO, international Board Member and serial entrepreneur. As CEO and Chairman of Scientific Learning Corporation, a neuroscience technology company, she built the company from pre-product to a highly successful IPO. Previously, she was vice president at Merrill Lynch Capital Markets, and a senior executive at Home Box Office and Rockefeller and Co. Two Stanford Business School cases have been written about her career, and she has been recognized as one of the most influential female Harvard Business School graduates.
In addition to the Tivic board, Karen currently serves on the boards of ResMed (NYSE: RSMD), OutSet Medical (NASDAQ: OM) and VIDA Diagnostics. She has extensive and operational experience building consumer health tech device companies. Karen is the former CEO and board member of Sandstone Diagnostics. Previously, she served as chairman of the board of Hygieia, Inc., and remains as an advisor to the CEO. Karen is an active mentor and advisor with Astia, a global nonprofit that supports high-potential female founders. She founded and ran Amira Medical until its sale to Roche Diabetes Care. She managed a variety of functions across the company at LifeScan and executed the sale of the company to Johnson & Johnson. She has received 11 patents, served on numerous boards and is active in non-profits that support female entrepreneurs. Karen was named Female Entrepreneur of the Year by the Stevie Awards, 2013, and Entrepreneurial Woman of the Year by Silicon Valley Women’s Fund, 2002.
Dean brings deep industry experience in allergy and asthma to the Board. He has previously served as CEO of Spirosure, a FeNO detection company for asthma diagnostics. He has also previously served as head of global marketing for Johnson & Johnson's Animas Corporation within their medical device & diagnostics division. He was head of strategy for Pfizer Pharmaceuticals U.S. Cardiovascular Unit, a division with about $7 billion in annual revenues. Zikria brings experience in strategic planning, scenario planning and analysis, and mergers and acquisitions, including sourcing, transactions and integration.